|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Income before taxes | |||||
| Adjustment for: | |||||
| Depreciation and amortization | |||||
| Foreign exchange on loans and derivative financial instruments | |||||
| Indexation accruals on assets and liabilities | |||||
| Write-offs in operations with disposal of investments | |||||
| Equity | |||||
| Losses (gains) on write-off/sale of assets | |||||
| Impairment losses - trade accounts receivable | |||||
| Change in liability provision | |||||
| Write-off and reversals for impairment - inventories | |||||
| Pension plans and other post-retirement benefits | |||||
| Provisions for tax, civil, labor and regulatory contingencies | |||||
| Interest expense | |||||
| Partial debt reversal through post-closing price adjustment - Garliava Acquisition | |||||
| Reversals of provisions for fines for canceling leases and dismantling contracts | |||||
| Adjustments for the reversal of provisions for customer refunds | |||||
| Adjustments for gains (losses) on the revaluation of equity interests in the acquisition of control and other investment gains | |||||
| Other | |||||
| Changes in assets and liabilities | |||||
| Trade accounts receivable | |||||
| Inventories | |||||
| Taxes recoverable | |||||
| Prepaid expenses | |||||
| Other assets | |||||
| Personnel, social charges and benefits | |||||
| Trade accounts payable | |||||
| Taxes, charges and contributions | |||||
| Write-offs for payments of provision for legal demands, contingent liabilities, fines for canceling lease contracts and amounts to be refunded to customers | |||||
| Other liabilities | |||||
| Total adjustments | |||||
| Cash generated from operations | |||||
| Interest paid | |||||
| Income and social contribution taxes paid | |||||
| Net cash generated by operating activities | |||||
| Cash flows from investing activities | |||||
| Additions to PP&E, intangible assets and others | |||||
| Proceeds from sale of PP&E | |||||
| Payment for acquisition of investments and capital contribution in subsidiary | |||||
| Receipts (payments), net of judicial deposits | |||||
| Net payments of receipts from financial investments | |||||
| Receipt of dividends and interest on equity | |||||
| Cash and cash equivalents due to the acquisition (sale) of companies | |||||
| Cash received from sale of investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Additions from loans and debentures | |||||
| Payments of loans, financing, debentures, leases, 5G licenses and contingent liabilities | |||||
| Receipts - derivative financial instruments | |||||
| Payments - derivative financial instruments | |||||
| Dividend and interest on equity paid | |||||
| Capital subscriptions made by noncontrolling shareholders in subsidiaries | |||||
| Payments to shareholders for reduction of share capital | |||||
| Receipts from reverse stock split and stock split | |||||
| Payments for reverse stock split and stock split | |||||
| Payments of costs related to reverse stock split and stock split operations | |||||
| Net cash used in financing activities | |||||
| Increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of the year | |||||
| Cash and cash equivalents at end of the year | |||||
Loading...
